vifor is accretive and seqirus is just fine with pandemic revenues this half and worst US flu season in 15 years to ensure demand for seasonal flu vaccine.
- Forums
- ASX - By Stock
- Csl is now a bargain
CSL
csl limited
Add to My Watchlist
0.91%
!
$239.02

vifor is accretive and seqirus is just fine with pandemic...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$239.02 |
Change
-2.200(0.91%) |
Mkt cap ! $115.8B |
Open | High | Low | Value | Volume |
$240.96 | $242.06 | $238.69 | $63.71M | 265.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 84 | $239.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$239.04 | 6 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 173 | 239.190 |
1 | 14 | 239.180 |
3 | 66 | 239.170 |
5 | 226 | 239.160 |
2 | 15 | 239.150 |
Price($) | Vol. | No. |
---|---|---|
239.220 | 85 | 13 |
239.230 | 101 | 10 |
239.240 | 1 | 1 |
239.250 | 46 | 3 |
239.260 | 10 | 1 |
Last trade - 13.54pm 25/06/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |